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Linkage Data Excluding a Locus for Multiple Endocrine
Neoplasia Type 2 Syndromes from the Distal Part of the
Short Arm of Chromosome 11
Kenneth K. Kidd, PhD,* Susan D. Kruger, PhD,* Daniela S. Gerhard, PhD,** Judith R. Kidd,*
David Housman, PhD,** and Joseph M. Gertner, MD***

A study designed to identify the location of a gene for
multiple endocrine neoplasia type 2 (MEN-2) is being
performed using a single large family segregating for
MEN-2A. Here we report our initial results using a set
of DNA restriction
fragment length
polymorphisms
spanning a 40 cM segment of the short arm of human
chromosome 11. The locus for MEN-2 in this family is
excluded from this entire region which includes an

oncogene, c-Ha-ras-1, two hormone loci, insulin and
parathyroid, and the five hemoglobin genes in the beta
hemoglobin gene duster. This is the first exclusion of
such a large continuous segment of the genome as a
location for a gene for MEN-2. However, because genetic heterogeneity
may exist for MEN-2, we cannot
exclude the possibility that in some other kindred a
locus in this region is responsible for MEN-2.

M ultiple e n d o c r i n e neoplasia type 2 (MEN-2) is a
syndrome characterized by pheochromocytoma and
medullary thyroid carcinoma; it is inherited in an autosomal dominant fashion w i t h nearly complete penetrance of some t u m o r by age 40 (1). While screening
tests allow early detection of tumors, the tests are unpleasant and costly. Identification of a closely linked
genetic marker w o u l d permit more accurate genetic
counseling and allow screening to be concentrated on
the 50% (or less) of family members actually carrying
the gene. Of more basic relevance is the insight into
tumorigenesis that w o u l d result f r o m identifying the
MEN-2 locus and its f u n c t i o n .

pheochromocytoma, hyperparathyroidism) is inherited
in a classic dominant fashion (1,2). W e showed by a
simulation study (unpublished results) that this family
could give statistically significant lod scores for markers
within 5 to 10 map units+ of the MEN-2 locus if those
markers were sufficiently heterozygous. We have used
a set of highly polymorphic DNA restriction fragment
length polymorphisms (RFLPs) as linkage markers and
here report our initial results excluding the MEN-2 locus
from a single block of chromosome 11 approximately 40
map units in length.

As with all syndromes of u n k n o w n etiology, a difficulty
in performing linkage analyses is the possibility of genetic heterogeneity—abnormal alleles at different loci
being the cause in different families. In order to maximize the ability to detect and to exclude linkages, it is
important that large, very informative families be studied. A family to be studied should have a sufficiently
large number of fully informative gametes identifiable
so that linkage w i t h i n a reasonable distance can be
demonstrated within the single pedigree. Thus, there
must be a large number of instances in which MEN-2 is
passed from parent to child and in which the linkage
phase of markers in the parents can be determined from
other aspects of the family structure. Moreover, with
delayed age of onset there should be relatively few
unaffected y o u n g offspring of affected individuals since
these young children provide little information.

Lymphoblastoid cell lines have been established f r o m
52 individuals in the multigenerational family we are
studying. It is p o w e r f u l for a linkage study in part
because 18 living individuals are affected. The DNA
isolated from these cell lines has been used to study
genetic linkage between MEN-2 and several RFLP loci on
the short arm of chromosome 11. These loci include the
beta hemoglobin gene cluster (HBBC), the insulin structural gene (INS), the c-Ha-ras-1 oncogene (HRASl), the
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Based on these considerations, we have concentrated
our linkage studies in one large family in which the full
MEN-2A syndrome (medullarycarcinomaof the t h y r o i d .

+Ed, note: 1 map unit is 1 centiMorgan (cM) = l % recombination.
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parathyroid hormone structural gene (PTH), and a locus
(D11S12) defined byan anonymousgenomic DNA clone
(3-5).
The beta hemoglobin gene cluster RFLPs were defined
primarily by the gamma probe on Hind Ill-digested
DNA, by the epsilon probe and the pseudobeta probe
on Hinc ll-digested DNA, and b y t h e beta probe on Bam
Hl-digested DNA (6); linkage analyses were done on the
four markers separately because the family structure
did not allow us to determine the multisite haplotypes
defined by the alleles at these individual sites. The
insulin RFLP was typed using genomic clones f r o m Bell,
etal on Sac 1-digested DNA and on Pvu ll-digested DNA
(7) . The HRASl RFLPwas typed on Bam Hl-digested DNA
using a DNA originally isolated by Shih and Weinberg
(8) . The D11S12 RFLP was typed on Bel l-digested DNA
using the anonymous probe pADJ-762 (9). The PTH RFLP
was typed on Pst 1-digested DNA using a cDNA probe
provided by H. M . Kronenberg and co-workers.

a particular concern for disorders, such as MEN-2,
which have an u n k n o w n pathogenesis. Linkage analyses are especially vulnerable to this possibility if lod
scores are based on summations f r o m results in many
separate families; a true linkage that exists in only a
subset of the families may well be missed. O u r studies
were concentrated in a single family large enough to
have high power for detecting linkage of a marker locus
w i t h the particular locus for MEN-2 segregating in this
family. While we can unequivocally exclude the locus
for MEN-2 that is segregating in this family f r o m a distal
segment o f t h e short arm of chromosome 11, we cannot
exclude the possibility that a locus in this part of chromosome 11 might be responsible for MEN-2 in some
other kindred.

TABLE
Linkage Analysis of MEN-2 with Chromosome 11 RFLPs*

The linkage analyses were done using the LIPED program of Ott (10) as modified by Hodge, et al (11) to
incorporate age-dependent penetrances. Unaffected
individuals were considered to have onset as a straightline function of age f r o m a penetrance of 0 at age 3 to a
maximum ultimate penetrance of .99 at age 35 and
thereafter. The frequency of phenocopies was considered to be .001 and a gene frequency for the MEN-2
allele of .0005 was assumed. Because of a few questionable diagnoses of individuals w h o were not obligate
carriers, two sets of analyses were p e r f o r m e d ; O n e with
the individuals w i t h questionable diagnoses considered
to be of u n k n o w n phenotype and one w i t h these individuals considered to be affected. Dead ancestors w h o
were obligate carriers but for w h o m no documentation
of disease could be uncovered were considered to be of
unknown phenotype in both analyses.

Locus

HRASl
INS
D11S12
HBBC
PTH

Recombination fraction
0

.o.->

.1

,1.5

-10.6
- 9.4
- 2.6
- 8.3
- 6.9

-3.5
-2.0
-0.5
-1.8
-1.9

-2.1
-1.0
-0.2
-1.0
-1.0

-1.3
-0.5
-0.1
-0.5
-0.6

*RFLP = Restriction fragment length polymorphism. Lod scores are given
for those recombination fractions for which clear exclusion of linkage
exists. Lod scores between MEN-2 and each of the indicated loci remained
negative to a recombination fraction of 0.5.

Reliably identifying all affected individuals was a difficult problem early in the course of this study. W i t h tests
now available, elevated calcitonin levels can be detected before the actual occurrence of malignant transformation, during the stage of C-cell hyperplasia or
perhaps before that. In t w o members in our family, the
screening test provided strong evidence for the presence of a malignancy or hyperplasia, and both patients
had thyroidectomy. However, no clear evidence of
either a t u m o r or C-cell hyperplasia could be d e m o n strated histologically. Demonstration of abnormally elevated stimulated calcitonin values in an individual at
50% prior risk of having inherited the gene is almost
certainly a true positive result. Nonetheless, we do not
yet know how often positive screening tests occur in the
absence of a t u m o r and are unable to accept that these
people are unquestionably affected. Results in the
Table are based on the conservative assumption that we
do not know the genotype of these t w o individuals. The
exclusion, which is unequivocal for this conservative
analysis, is even stronger if we were to assume that the
two individuals are affected. Accordingly, our overall
conclusion is not affected by this slight uncertainty.

Results
There was no qualitative difference between the t w o
sets of analyses that differed in their treatment of individuals with questionable diagnoses. The lod scores in
the Table represent the results obtained w h e n individuals w h o had no sign of t u m o r tissue f o l l o w i n g a
thyroidectomy were considered to be u n k n o w n for
MEN-2 phenotype. The analyses in w h i c h these individuals were considered to be definitely affected w i t h
MEN-2 gave even more negative lod scores.

Discussion
W i t h any human genetic disorder, a constant concern
f o r g e n e t i c analysis is t h e p o s s i b i l i t y of g e n e t i c
heterogeneity—that different loci are responsible for
the illness in different families. Genetic heterogeneity is
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The analyses for the beta hemoglobin gene cluster are
represented in the Table by the gamma hemoglobin
polymorphisms. The other loci in the HBBC all gave
strongly negative lod scores w i t h MEN-2 but were individually less informative than the gamma hemoglobin
polymorphisms. Since all of the markers occur within a
60 kb block of DNA, the various markers largely provide
redundant information. Had the structure of the family
allowed us to construct multisite haplotypes that were
segregating, the nonredundant information w o u l d have
been utilizable. However, since the existing exclusion is
so definitive, little w o u l d have been gained.
The loci are listed in the Table in the order in which they
exist on chromosome 1 1 , f r o m the locus closest to the
tip of the short arm (HRASl) to the locus closest to the
c e n t r o m e r e (PTH). Since linkage is considered excluded for those recombination frequencies with lod
scores less than -2, we can see that the MEN-2 locus is
excluded f r o m being w i t h i n 5 map units on either side of
INS, from almost 12 map units on either side of HRASl,
and from about 4 map units on either side of both HBBC
and PTH. Only for D11S12 is the excluded region quite
small. However, since D11S12 is approximately 3 map
units f r o m HBBC and about 6 f r o m HRASl, it is within
the regions excluded by those t w o loci. The overlapping
regions of unambiguous exclusion encompass the entire region f r o m HRASl to HBBC. O n l y between HBBC
and PTH might there be a small region that is not definitively excluded, especially if HBBC and PTH are substantially more than 10 map units apart; the distance
between these loci is currently the least precisely estimated part of this linkage g r o u p . While we conclude
that the entire region f r o m HRASl to PTH is excluded by
these analyses, a full multipoint linkage analysis might
have given more definitive results f o r t h e central part of
the region between HBBC and PTH. It could not have
given a more definitive result for the remaining section
since all of the exclusions are mutually overlapping.
Two of the chromosome 11 loci are of particular interest
with respect to MEN-2; HRASl and PTH. HRASl was the
first of the oncogenes to be discovered. While our
knowledge of several different oncogenes and their
functions n o w makes HRASl seem a not particularly
interesting candidate for being identical to MEN-2, this
was not so obvious three years ago at the time these
studies were initiated. O u r results convincingly exclude
this oncogene f r o m being the cause of MEN-2. Moreover, the study illustrates that the existence of nearby
markers (INS, D11S12, HBBC) w o u l d have allowed us to
reach the same conclusion about HRASl even if we had

not had a p r o b e or identifiable polymorphisms for
HRASl. This multipoint approach illustrates the growing power of genetic linkage analyses using numerous
closely l i n k e d DNA p o l y m o r p h i s m s . Similarly, our
strong exclusion of the PTH locus is of interest not only
because one might hypothesize a function of that locus
related to MEN-2 but also because we have recently
obtained preliminary data (unpublished) suggesting
that the calcitonin gene is closely linked to the PTH
locus. Thus, the strongly negative lod scores w i t h PTH
permit the preliminary suggestion that the calcitonin
locus is not involved in the occurrence of MEN-2. O b v i ously, we will attempt a more direct test of that hypothesis using RFLPs identified by the calcitonin clone.

Conclusion
We have excluded the MEN-2 locus that is segregating in
our kindred f r o m being in the distal portion of the short
arm of chromosome 11. The excluded continuous block
of DNA represents approximately 1 % of t h e t o t a l human
genome. The linkage result is based on segregating
variants at a large number of polymorphic sites at five
closely linked points of the chromosome. The major
significance of this study, aside f r o m the exclusion of
one identified oncogene f r o m being involved, is the
demonstration of the use of multiple markers w i t h i n 5 to
10 map units of each o t h e r t o p r o v i d e a d d i t i o n a l
strength to linkage analyses and added confidence in
the results. W h e n linkage analyses are ultimately performed in the area of the genome close to the locus for
MEN-2, the same sort of power should result f r o m the
use of multiple markers in detecting positive linkage
and giving added confidence in the localization of the
MEN-2 locus. Once the locus is detected in a large
family such as ours, it will be necessary to determine
whether the same locus is involved in other families
segregating for MEN-2 or for pure MTC. Having multiple
markers in the region being studied will be important
for guaranteeing that some closely linked marker is
segregating in each of the families to be studied.
While it has taken three years to exclude approximately
1 % of the genome, the entire family has n o w been
collected, cell lines established, and DNA samples prepared. At the rate w i t h which new markers are being
discovered and mapped (12), it should be possible to
screen at least 50% of the genome w i t h i n the next year
or t w o . Thus, these approaches demonstrate the power
of a linkage approach and the high probability of successfully locating the locus in the near f u t u r e .
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